Bavarian Nordic A/S (CPH:BAVA)
197.20
+3.60 (1.86%)
May 19, 2026, 12:07 PM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 14.81 billion as of May 19, 2026. Its market cap has increased by 24.43% in one year.
Market Cap
14.81B
Enterprise Value
12.66B
Revenue
5.96B
Ranking
n/a
PE Ratio
13.05
Stock Price
197.20
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 14.81B, an increase of 34,569.41%. That is a compound annual growth rate of 23.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 14.40B | -3.58% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.33T |
| Genmab | 103.38B |
| Coloplast | 89.91B |
| ALK-Abelló | 56.01B |
| H. Lundbeck | 39.95B |
| Zealand Pharma | 21.94B |
| Ambu A/S | 16.54B |
| GN Store Nord | 13.76B |